Sidney Taurel Quotes (27 Quotes)

We deeply regret the 1998 conduct, which has resulted in a federal misdemeanor charge. We take seriously our responsibilities to abide by all the laws governing our business practices and are committed to ensuring our employees' actions reflect the highest legal and ethical standards of conduct. Although the government has not charged Lilly with any unlawful intent, we will continue to take steps designed to assure that Lilly's promotional activities remain fully compliant.

The rapid completion of the share repurchase program, coupled with the initiation of a new program, reflect the board's continued high level of confidence in the future of the company,

I hope they won't push too much farther. If they stopped right now, it'd be fine with me.

He is very well-prepared for the vital role he will play, and I look forward to having him join our senior leadership team.

We want to be sure that our leadership team is in the best position to help people throughout the company deliver for the customer now and in the future. John's new role is an important step in making that happen.

By taking advantage of this opportunity, Lilly will be able to enhance its focus on pharmaceutical innovation, ... We found Rite Aid's offer attractive because of its value to Lilly and the many synergistic opportunities PCS will have when combined with Rite Aid.

Through Charlie's leadership, we have built a world-class financial organization and strengthened Lilly's reputation for sound financial operations.

As we see the cost-containment methods being used by the private sector being now applied now to this Medicare business, I think those plans will extract higher and higher discounts from the industry,

With nearly two months of Prozac sales data available, the erosion in prescriptions is the most severe ever for a blockbuster product in our industry,

As our product line continues to become more diversified, we have become less dependent on Prozac performance. Major products introduced in the last five years accounted for fully one-third of our sales in 1999 and had a combined growth rate of 41 percent during the year.

While the first quarter was a challenging quarter, it underscores the importance of building a strong pipeline and effectively launching new products,

the right dose of the right drug to the right patient at the right time.

Whether they are patients needing access to affordable health care or survivors of a disaster, we do our best to ensure that people in need are not forgotten. Our founders established these values nearly 130 years ago, and we live by them today.

Now that we've done all this, our destiny is in our hands. It's up to us to perform. This new structure will help us better execute our strategy.

Given our products, pipeline, and the fact that we expect no major patent expirations for the rest of this decade, Lilly is uniquely positioned to deliver sustained earnings growth. For 2006, we anticipate earnings per share of 3.10 to 3.20, which represents 8 to 12 growth compared with expected 2005 adjusted earnings. This growth rate is nearly double the average Wall Street consensus forecast for large-cap pharmaceutical companies.

During his tenure, Charlie used his broad business experiences and sound judgment to help steer the company through many challenges over the past decade. Through Charlie's leadership, we have built a world-class financial organization and strengthened Lilly's reputation for sound financial operations, transparency in our financial reporting, and strong internal controls.

Our overall growth for the next several quarters will be generated from newer product sales, line extensions of existing products and recent product launches, ... As a result, we will rely less on Prozac sales growth.

We are seeing a very resilient economy and one that seems to be growing in every part of the world. Just about every region is growing and it's very encouraging.

As we expected, the second half of 2005 is bringing stronger sales and earnings growth,

Our strong bottom-line results in the first quarter reflect the execution on our commitment to grow sales at a faster rate than our expenses.

That means up to 10 products that will be launched between 2001 and 2004, which will help us weather the storm,

We are asking for a rehearing on the decision by the appeals court, and if that fails we have the option of going to the Supreme Court, so the case is not over,

Charlie's leadership was pivotal in our drive to increase productivity in every part of Lilly. His ability to transform our organization and raise the bar in every area of performance has been invaluable. His dedication to leadership development is also evident. He leaves behind a strong bench of valued leaders who add value throughout the company.

In the short term, I think this will increase access to some people who are not poor enough to be on Medicaid,

I am committing all the necessary resources of the company to address these issues, ... We will continue to work closely with the FDA in order to deliver on our promise to bring these innovative new medicines to patients as quickly as possible.

In a year of urgent needs, Lilly and its employees stepped forward with extraordinary efforts. To ease the suffering of hurricane and earthquake victims, we gave essential medicines, cash, and supplies. To ensure that seniors and low-income patients had affordable access to drugs, we offered six patient assistance programs. And to halt the spread of multi-drug-resistant tuberculosis, we partnered with the World Health Organizations and other groups to share expertise, improve treatment, and save lives.

Looking forward to 2006, our newer products should grow to about 24 percent of revenues and earnings per share should grow 8 to 11 percent, representing top-tier growth for large-cap pharmaceutical companies.